课题基金 / 基金详情

MECHANISM OF THE ACTIVATION OF LATENT TGF-beta IN THE VASCULAR WALL

MECHANISM OF THE ACTIVATION OF LATENT TGF-beta IN THE VASCULAR WALL
血管壁中潜在 TGF-β 的激活机制
批准号:
06836015
负责人:
SATO Yasufumi
金额:
$1.28万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995

项目摘要

项目成果

SATO Yasufumi的其他基金

相似基金

相关文献

中文摘要
翻译
TGF-β是影响包括动脉粥样硬化在内的血管疾病进程的最重要的细胞因子之一。由于TGF-β总是以潜伏形式分泌,因此分泌后潜伏TGF-β的活化是表达其活性的关键步骤。本研究者先前已经发现,当内皮细胞(EC)和平滑肌细胞(SMC)接触时,潜伏的TGF-β被激活。这种激活需要在EC上表达的u-PA-纤溶酶活性和与SMC结合的潜在TGF-β。由于平滑肌细胞并不总是与血管壁中的内皮细胞接触,因此需要阐明同型平滑肌细胞中潜伏的TGF-β激活的机制。将外源性u-PA加入SMC培养物中,u-PA与受体结合并在细胞表面表达其活性。在这种条件下,潜伏的TGF-β被有效激活。u-PA对潜伏性TGF-β激活的这种作用被针对潜伏性相关肽(LTP)的单克隆抗体KM-704所消除,KM-704抑制潜伏性TGF-β与SMC的结合。这些结果表明,u-PA和潜伏的TGF-β的同时结合在同型SMC中产生活性TGF-β。进一步表征了外源TGF-β与SMC的结合特性。KM-704的抗原表位定位于大肠杆菌N端,由约80个氨基酸组成。在该区域中没有任何已知的蛋白质-蛋白质相互作用的序列。因此,潜伏的TGF-β通过一个新的结合位点与SMC结合。
英文摘要
TGF-beta is one of the most important cytokines affecting the course of vascular diseases including atherosclerosis. Since TGF-beta is always secreted in a latent from, the activation of latent TGF-beta after secretion is the crucial step expressing its activity. The present investigator has previously found that latent TGF-beta is activated when endothelial cells (ECs) and smooth muscle cells (SMCs) are in contact. This activation requires u-PA-plasmin activities expressed on ECs and latent TGF-beta bound to SMCs. Since SMCs are not always in contact with ECs in the vascular wall, a mechanism for the activation of latent TGF-beta in homotypic SMCs needs to be elucidated.The present study revealed that SMCs expressed urokinase-type PA (u-PA) receptor on the cell surface. When exogenous u-PA was added to SMC cultures, u-PA bound to the receptor and expressed its activity on the cell surface. Under this condition, latent TGF-beta was efficiently activated. This effect of u-PA on the activatipn of latent TGF-beta was abrogated by the monoclonal antibody against latency-assosiated peptide (LAP) ; KM-704, which inhibits the binding of latent TGF-beta to SMCs. These results indicate that the simultaneous bindings of u-PA and latent TGF-beta generates active TGF-beta in homotypic SMCs. The binding property of lanent TGF-beta to SMCs was further characterized. The epitope of KM-704 was found to be located on the N-terminal region of LAP consisted with about 80 amino acids. There is not any known sequences for protein-protein interaction in this region. Thus, latent TGF-beta binds to SMC via a novel binding site to LAP.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
H.Abe, M.Abe, K.Tanaka, C.Iwasaka, and Y.Sato: "Simultaneou binding of u-PA and latent TGF-beta is required for the activation of latent TGF-beta in homotypic smooth muscle cells." Tohoku J.Exp.Med.179. 23-34 (1996)
H.Abe、M.Abe、K.Tanaka、C.Iwasaka 和 Y.Sato:“同型平滑肌细胞中潜在 TGF-β 的激活需要 u-PA 和潜在 TGF-β 同时结合。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sato, Y.: "Activation of latent TGF-beta at the vascular wall. Roles of endothelial cells and mural pericytes or smooth muscle cells." J.Atheroscler.Thromb.2. 24-29 (1995)
Sato, Y.:“血管壁潜在 TGF-β 的激活。内皮细胞和壁周细胞或平滑肌细胞的作用。​​”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sato,T.: "Activation of latent TGF-β at the vascular wall. Roles of endothelial cells and mural pericytes or smooth muscle cells." Journal of Atherosclerosis and Thrombosis. 2. 24-29 (1995)
Sato, T.:“血管壁潜在 TGF-β 的激活。内皮细胞和壁周细胞或平滑肌细胞的作用。​​动脉粥样硬化和血栓形成杂志”2. 24-29 (1995)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
H.Abe,M.Abe,K.Tanaka,C.Iwasaka,and Y.Sato: "Simultaneou binding of u-PA and latent TGF-β is required for the activation of latent TGF-β in homotypic smooth muscle cells." The Tohoku Journal of Experimental Medicine. 179. 23-34 (1996)
H.Abe、M.Abe、K.Tanaka、C.Iwasaka 和 Y.Sato:“同型平滑肌细胞中潜在 TGF-β 的激活需要 u-PA 和潜在 TGF-β 同时结合。”东北实验医学杂志。179. 23-34 (1996)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Identification of antigens for monoclonal antibodies against the mouse blastsyst
Signaling of intrinsic angiogenesis inhibition in cancer tissues
  • 批准号:
    17014006
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
  • 资助金额:
    $36.42万
  • 财政年份:
    2005
  • 负责人:
    SATO Yasufumi
  • 依托单位:
Molecular mechanism of vascular formation
  • 批准号:
    09281101
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas (A)
  • 资助金额:
    $127.87万
  • 财政年份:
    1997
  • 负责人:
    SATO Yasufumi
  • 依托单位:
Inhibition of the binding of basic fibroblast growth factor to its receptor and angiogenesis by synthetic peptides related to platelet factor 4
  • 批准号:
    03670629
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 资助金额:
    $1.34万
  • 财政年份:
    1991
  • 负责人:
    SATO Yasufumi
  • 依托单位:
国内基金
海外基金
BRD4通过结合TEAD1调控β细胞增殖分化的机制研究
  • 批准号:
    82370801
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    李峰
  • 依托单位:
PCBP1和PCBP2调控cGAS的相变和酶活的机制研究
  • 批准号:
    32370928
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2023
  • 负责人:
    孙钦秒
  • 依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    32170319
  • 项目类别:
    面上项目
  • 资助金额:
    58.00万元
  • 批准年份:
    2021
  • 负责人:
    董春海
  • 依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    58万元
  • 批准年份:
    2021
  • 负责人:
    董春海
  • 依托单位: